Omeros Corp. (OMER)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$18.95-0.84%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OMER
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | — | — | 73.8 | 111.8 | 29.9 | 64.8 | 41.6 | 13.5 | 0.5 | 1.6 | 6.0 | 4.5 |
| Total Revenues | — | — | — | — | — | — | — | — | 29.9 | 64.8 | 41.6 | 13.5 | 0.5 | 1.6 | 6.0 | 4.5 |
| Cost of Revenues | — | — | — | — | — | — | 0.9 | 0.9 | 0.5 | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 47.3 | 41.5 | 49.7 | 49.7 | 50.7 | 54.8 | — | — | — | — | — | — | — | — | — | — |
| R&D Expenses | 62.6 | 81.3 | 119.5 | 114.9 | 112.7 | 118.8 | 107.6 | 106.3 | 89.9 | 55.6 | 50.7 | 48.4 | 47.9 | 36.3 | 31.9 | 23.7 |
| Operating Income | (72.8) | (122.8) | (169.3) | (164.5) | (163.4) | (173.6) | (156.9) | (146.0) | (112.2) | (43.9) | (54.3) | (71.2) | (70.0) | (50.5) | (36.9) | (27.4) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | (1.0) | 24.7 | 30.8 | 22.7 | 19.7 | 26.8 | 22.7 | 16.3 | 11.0 | 7.8 | 3.6 | 3.5 | 2.4 | 1.7 | 1.9 |
| Interest & Investment Income | — | 2.3 | 8.4 | 14.7 | 2.2 | — | — | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | 16.1 | 20.5 | — | — | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (2.8) | — | (174.9) | (182.0) | (191.5) | (196.4) | (167.1) | (139.7) | — | — | — | — | — | — | — |
| Income Tax Expense | — | 2.0 | 2.3 | 0.0 | 0.0 | 0.0 | (23.3) | (19.8) | (12.9) | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | 124.8 | (3.4) | (156.8) | (117.8) | 47.4 | 194.2 | (138.1) | (84.5) | (126.8) | (53.5) | (66.7) | (75.1) | (73.7) | (39.8) | (38.4) | (28.5) |
| Per Share | ||||||||||||||||
| Basic EPS | 1.73 | (0.05) | (2.70) | (1.88) | 0.76 | 3.12 | (2.41) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | 1.39 | (0.05) | — | (1.88) | 0.76 | 3.12 | (2.41) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 72.1 | 63.5 | 58.2 | 62.7 | 62.7 | 62.3 | 57.2 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 89.6 | — | — | — | 62.7 | 62.3 | 57.2 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (121.8) | (168.3) | (163.6) | (163.4) | (172.2) | (155.3) | (144.2) | (111.3) | (43.3) | (54.0) | (71.0) | (69.7) | (50.2) | (36.6) | (27.0) |
| EBIT | (72.8) | (122.8) | (169.3) | (164.5) | (163.4) | (173.6) | (156.9) | (146.0) | (112.2) | (43.9) | (54.3) | (71.2) | (70.0) | (50.5) | (36.9) | (27.4) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 11.8% | 11.8% | 9.3% | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.